Literature DB >> 15097885

Systemic manifestations in response to mydriasis and physical examination during screening for retinopathy of prematurity.

Ryan Rush1, Sloan Rush, John Nicolau, Karen Chapman, Mubariz Naqvi.   

Abstract

OBJECTIVE: To determine whether adverse effects manifested via vital sign changes during the screening examination for retinopathy of prematurity (ROP) are due to the pharmacologic properties of the eye drops or to physical manipulation of the eyes. The authors also investigated the relationship between distress during the screening process and the severity of prematurity of the infant. DESIGN AND METHODS: A prospective observational study was designed that enrolled all infants either weighing < or =1500 g or who were < or =32 weeks gestational age at birth who were admitted to the neonatal intensive care unit (NICU) at Northwest Texas Hospital or Baptist St. Anthony's Hospital from June 2002 to February 2003. Thirty participants were enrolled in this study. Blood pressure, pulse, temperature, respiratory rate, and O2 saturation were recorded at different time intervals during the examination. Infants were excluded from the study if they were on the ventilator, considered acutely ill, born with significant birth defects, or currently taking inotropic drugs, or had received albuterol 2 hours before the examination.
RESULTS: Oxygen saturation and pulse rate following physical manipulation of the eyes significantly varied from baseline values and the values obtained during the three instillations of topical mydriatics. No significant changes in blood pressure, temperature, or respiratory rate from their respective baseline values were observed throughout the ROP screening examination. Gestational age of the infant did not correlate with level of distress during the examination.
CONCLUSION: Regardless of the severity of prematurity, infants seem to undergo significant distress during the eyelid speculum examination. Thus ophthalmologists should take into consideration the infant's discomfort caused by physical manipulation of the eyes and attempt to perform the examination as swiftly, yet safely, as possible using topical anesthetic.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15097885     DOI: 10.1097/00006982-200404000-00009

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  26 in total

1.  Do we screen very premature babies too early for retinopathy of prematurity?

Authors:  G Kontos; A Khan; B W Fleck
Journal:  Eye (Lond)       Date:  2016-01-22       Impact factor: 3.775

2.  Is there a role for high-frequency ultrasonography in clinical staging of retinopathy of prematurity?

Authors:  Danny H Kauffinann Jokl; Ronald H Silverman; Sheri L Nemerofiky; Steven A Kane; Michael F Chiang; Robert Lopez; Grace Lee
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2006 Jan-Feb       Impact factor: 1.402

3.  N-terminal B-type natriuretic peptide urinary concentrations and retinopathy of prematurity.

Authors:  Christoph Bührer; Ömer Erdeve; Anton van Kaam; Angelika Berger; Evelyn Lechner; Benjamin Bar-Oz; Karel Allegaert; Tom Stiris; İstemi Han Çelik; Janet Berrington
Journal:  Pediatr Res       Date:  2017-08-16       Impact factor: 3.756

4.  Evaluation of retinopathy of prematurity screening in reverse Kangaroo Mother Care: a pilot study.

Authors:  T R Padhi; D Sareen; L Pradhan; S Jalali; S Sutar; T Das; R R Modi; U C Behera
Journal:  Eye (Lond)       Date:  2015-01-23       Impact factor: 3.775

5.  Systemic Absorption of Cyclopentolate and Adverse Events After Retinopathy of Prematurity Exams.

Authors:  Anita Mitchell; Richard W Hall; Stephen W Erickson; Charlotte Yates; Scott Lowery; Howard Hendrickson
Journal:  Curr Eye Res       Date:  2016-05-09       Impact factor: 2.424

6.  Physiologic effects of retinopathy of prematurity screening examinations.

Authors:  Anita J Mitchell; Angela Green; Debra A Jeffs; Paula K Roberson
Journal:  Adv Neonatal Care       Date:  2011-08       Impact factor: 1.968

Review 7.  Telemedicine for retinopathy of prematurity diagnosis: evaluation and challenges.

Authors:  Grace M Richter; Steven L Williams; Justin Starren; John T Flynn; Michael F Chiang
Journal:  Surv Ophthalmol       Date:  2009-08-08       Impact factor: 6.048

8.  The local vasoconstriction of infant's skin following instillation of mydriatic eye drops.

Authors:  Atilla Alpay; Bahri Ermis; Silay C Ugurbas; Fatih Battal; Haci Murat Sagdik
Journal:  Eur J Clin Pharmacol       Date:  2010-09-11       Impact factor: 2.953

Review 9.  Retinopathy of prematurity: a review of risk factors and their clinical significance.

Authors:  Sang Jin Kim; Alexander D Port; Ryan Swan; J Peter Campbell; R V Paul Chan; Michael F Chiang
Journal:  Surv Ophthalmol       Date:  2018-04-19       Impact factor: 6.048

10.  Risk factors for retinopathy of prematurity: insights from outlier infants.

Authors:  Alexander D Port; R V Paul Chan; Susan Ostmo; Dongseok Choi; Michael F Chiang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2014-07-23       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.